Bone mineral density in juvenile systematic lupus erythematosus

Brazilian Journal of Medical and Biological Research

Volumn 35, Issue 10, 2002, Pages 1159-1163

  Castro, T C M ^a   Terreri, M T ^a   Szejnfeld, V L ^a   Castro, C H M ^a   Fisberg, M ^a   Gabay, M ^a   Hilario M O E ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adolescents; Bone mineral density; Children; Corticosteroids; Osteoporosis; Systematic lupus erythematosus

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; AGE; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE MASS; BONE MINERAL; BRAZIL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; DOSE RESPONSE; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LUMBAR SPINE; MEDICAL RECORD; OSTEOLYSIS; PREDICTION; PREVALENCE; PUBERTY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0036818720     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2002001000008     Document Type: Article

References (30)

1. Warady BD, Lindsley CB, Robinson FG & Lukert BP (1994). Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. Journal of Rheumatology, 21: 530-535.
2. Pepmueller PH, Cassidy JT, Allen SH & Hillman LS (1996). Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis and Rheumatism, 39: 746-757.
3. Perez MD, Abrams AS, Koenning G, Stuff JE, O'Brien KO & Ellis KJ (1994). Mineral metabolism in children with dermatomyositis. Journal of Rheumatology, 21: 2364-2369.
4. Dykman TR, Haralson KM, Gluck OS, Murphy WA, Teitelbaum SL, Hahn TJ & Hahn BH (1984). Effects of 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis and Rheumatism, 27: 1336-1343.
5. Dykman TR, Gluck OS, Murphy WA, Hahn TJ & Hahn BH (1985). Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis and Rheumatism, 28: 361-368.
6. Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Eberl S & Champion GD (1986). Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Annals of the Rheumatic Diseases, 45: 950-953.
7. Sambrook PN, Cohen ML, Eisman JÁ, Pocock NA, Champion GD & Yeates MG (1989). Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Annals of the Rheumatic Diseases, 48: 535-538.
8. Hajiroussou VJ & Webley M (1984). Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. Annals of the Rheumatic Diseases, 43: 24-27.
9. Dhillon BV, Davies MC, Hall ML, Round JM, Ell PJ, Jacobs HS, Snaith ML & Isenberg DA (1990). Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy X-ray absorptiometry. Annals of the Rheumatic Diseases, 49: 624-626.
10. Kalla AA, Fataar AB, Jessop SJ & Bewerunge L (1993). Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis and Rheumatism, 36: 1726-1734.
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N & Winchester RJ (1982). The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 25: 1271-1277.
12. De Schepper J, Derde MP, Van den Broeck M, Piepsz A & Jonckheer MH (1991). Normative data for lumbar spine bone mineral content in children: Influence of age, height, weight and pubertal stage. Journal of Nuclear Medicine, 32: 216-220.
13. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F & Roig-Escofet D (1995). Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Annals of the Rheumatic Diseases, 54: 274-276.
14. Sinigaglia L, Varenna M, Binelli L, Zucchi F, Ghiringhelli D & Fantini F (2000). Bone mass in systemic lupus erythematosus. Clinical and Experimental Rheumatology, 18 (Suppl 21): S27-S34.
15. Pons F, Peris P, Guanabens N, Font J, Huguet M, Espinosa G, Ingelmo M, Munoz-Gomez J & Setoain J (1995). The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in premenopausal women. British Journal of Rheumatology, 34: 742-746.
16. Trapani S, Civinini R, Ermini M, Paci E & Falcini F (1998). Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatology International, 18: 45-49.
17. Falcini F, Bindi G, Ermini M, Galluzzi F, Poggi G, Rossi S, Masi L, Cimaz R & Brandi ML (2000). Comparison of quantitative calcaneal ultrasound and dual energy X-ray absorptiometry in the evaluation of osteoporotic risk in children with chronic rheumatic diseases. Calcified Tissue International, 67: 19-23.
18. Reid IR (1989). Pathogenesis and treatment of steroid osteoporosis. Clinical Endocrinology, 30: 83-103.
19. Michel BA, Bloch DA & Fries JF (1991). Predictors of fractures in early rheumatoid arthritis. Journal of Rheumatology, 18: 804-808.
20. Reid M, Nicoll JJ, Smith MA, Higgins B, Tothill P & Nuki G (1986). Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. British Medical Journal, 293: 1463-1466.
21. Adinoff AD & Hollister JR (1983). Steroid-induced fractures and bone loss in patients with asthma. New England Journal of Medicine, 309: 265-268.
22. Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G & Morand E (1997). Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. Journal of Rheumatology, 24: 1922-1929.
23. Sabatier JP, Guaydier-Souquieres G, Laroche D, Benmalek A, Fournier L, Guillon-Metz F, Delavenne J & Denis AY (1996). Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10-24 years of age. Osteoporosis International, 6: 141-148.
24. Sabatier JP, Guaydier-Souquieres G, Benmalek A & Marcelli C (1999). Evolution of lumbar bone mineral content during adolescence and adulthood: a longitudinal study in 395 healthy females 10-24 years of age and 206 premenopausal women. Osteoporosis International, 9: 476-482.
25. Bonjour JP, Theintz G, Buchs B, Slosman D & Rizzoli R (1991). Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. Journal of Clinical Endocrinology and Metabolism, 73: 555-563.
26. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC & Bonjour JP (1992). Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. Journal of Clinical Endocrinology and Metabolism, 75: 1060-1065.
27. Grondal G, Gunnarsson I, Ronnelid J, Rogberg S, Klareskog L & Lundberg I (2000). Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clinical and Experimental Rheumatology, 18: 565-570.
28. Tanaka Y, Watanabe K, Suzuki M, Saito K, Oda S, Suzuki H, Eto S & Yamashita U (1989). Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus. Journal of Clinical Immunology, 9: 415-420.
29. Babini SM, Arturi A, Marcos JC, Babini JC, Iniguez AM & Morteo OG (1988). Laxity and rupture of the patellar tendon in systemic lupus erythematosus. Association with secondary hyperparathyroidism. Journal of Rheumatology, 15: 1162-1165.
30. Wallace DJ (1993). The endocrine system and urogenital tract. In: Wallace DJ & Hahn BH (Editors), Dubois' Lupus Erythematosus. Lea and Febiger, Philadelphia, PA, USA, 407.